NOT KNOWN FACTUAL STATEMENTS ABOUT SODIUM PENTOBARBITAL

Contraindicated (1)pentobarbital will reduce the extent or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can result in lessened serum concentrations and lack of antimalarial efficacypentobarbital will lessen the extent or effect of alosetron by impact